Bio Rad Profile

<div class='logoBackup' style='background:#0D8ECF;color: white;font-size:3em;;'>BIO</div>

Performance

6 / 100

Odds of Distress

Analyze Filter   Earning Report: February 27, 2020
Equity ratings for Bio Rad Laboratories are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting October 20, 2019 and ending today January 18, 2020. Click here to learn more.

Bio Rad Profile

Upcoming quarterly earning report is expected on February 27, 2020. Bio-Rad Laboratories, Inc. develops, manufactures, and markets products and solutions for the life science research and clinical diagnostic markets in Europe, the Pacific Rim, the United States, and internationally. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California. Bio Rad operates under Medical Devices classification in USA and is traded on BATS Exchange. It employs 8000 people. more on Bio Rad
Bio Rad Fama & French Measuring and Control Equipment
Measuring and Control Equipment
Fama & French Classification
Bio Rad Laboratories SEC Filings
Bio Rad SEC Filings
Security & Exchange Commission EDGAR ReportsView All
NameBio Rad Laboratories
PresidentMichael CrowleyView All
Thematic Classifications
Active Investing Ideas
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Bond Rating
RegionNorth America
LocationCalifornia; U.S.A
Business Address1000 Alfred Nobel Drive, Hercules, CA 94547, United States
Cash and Equivalents
Specialization
Healthcare, Medical Devices
InstrumentUSA Stock View All
Net Income
ExchangeBATS Exchange
CIK Number0000012208
ISINUS0905722072
CUSIP090572207
Net Cash Flow from Operations
Older SymbolBIO
SectorHealthcare
IndustryMedical Devices
BenchmarkDOW
Websitewww.bio-rad.com
Phone510 724 7000
CurrencyUSD - US Dollar
Bio Rad Laboratories (BIO) is traded on BATS Exchange in USA. It is located in 1000 Alfred Nobel Drive, Hercules, CA 94547, United States and employs 8,000 people. Bio Rad Laboratories was previously known as Bio-Rad Laboratories and was traded on BATS Exchange under the symbol BIO. Bio Rad is listed under Measuring and Control Equipment category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with total capitalization of 9.84 B. Bio Rad Laboratories runs under Healthcare sector within Medical Devices industry. The entity has 24.7 M outstanding shares of which 570.94 K shares are currently shorted by investors with about 2.3 days to cover shorted positions. BIO RAD LABS CL A has about 979.25 M in cash with 403.1 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 32.71.
Check Bio Rad Probability Of Bankruptcy

Ownership Allocation (%)

Bio Rad Target Price Odds Analysis

Odds Below 376.43HorizonTargetOdds Above 376.43
87.20%30 days 376.43 12.64%
Based on normal probability distribution, the odds of Bio Rad to move above current price in 30 days from now is about 12.64 (This Bio Rad Laboratories probability density function shows the probability of Bio Rad Stock to fall within a particular range of prices over 30 days) .

Bio Rad Laboratories Top Holders

Bio Rad Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Artemis Investment Management LlpCommon Shares112.6 K40.7 M
State Of Alaska Department Of RevenueCommon Shares4.8 K1.8 M
View Bio Rad Diagnostics

Bio Rad Laboratories Income Statement Over Time

Direct Expenses    Earning Before Interest and Taxes EBIT    Net Income    

Bio Rad Key Fundamentals

Bio Rad Against Markets

Did you try this?

Run Global Markets Map Now

   

Global Markets Map

Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
All  Next Launch Module

Bio Rad Upcoming and Recent Events

Bio Rad Company Earnings Announcements Dates

Upcoming Quarterly Earning ReportFebruary 27, 2020
Next Earnings ReportMay 13, 2020
Next Fiscal Quarter EndDecember 31, 2019
Next Fiscal Year EndFebruary 27, 2020
Last Quarter Report DateSeptember 30, 2019
Last Earning Anouncement DateDecember 31, 2018

Bio Rad Corporate Filings

Bio Rad SEC Reporting

Regulation FD Disclosure
Cost Associated with Exit or Disposal Activities
Financial Statements and Exhibits. Results of Operations and Financial Condition
Unclassified Corporate Event

Bio Rad Corporate Directors

Gregory Hinckley Lead Independent Director
Melinda Litherland Independent Director
Jeffrey Edwards Independent Director
Continue to Trending Equities. Please also try Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Company logos by clearbit